Physician

Amee Majmundar, M.D.

According to 2025 Medicare claims, Amee Majmundar, M.D. (NPI: 1093794620) practices allergy/immunology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60467-8898. Majmundar is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Majmundar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 217 traditional Medicare patients, billed 8,946 HCPCS/CPT codes, and received $134,035 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 754 prescription claims across 202 beneficiaries totaling $262,266 in drug costs, led by Xolair (Omalizumab). DME data shows 117 claims. Open Payments data shows 48 records totaling $1,197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $32,282 to $134,035. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,703 to $262,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	95	2,620	$32,282
2016	127	2,898	$40,072
2017	153	4,302	$48,411
2018	230	8,783	$126,840
2019	256	8,724	$121,083
2020	226	6,207	$112,678
2021	251	8,131	$168,144
2022	202	6,021	$134,165
2023	218	8,364	$155,297
2024	217	8,946	$134,035

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	211	$14,703
2016	67	221	$12,897
2017	100	300	$29,412
2018	138	554	$78,781
2019	172	648	$74,361
2020	174	697	$83,464
2021	187	670	$152,961
2022	164	581	$172,464
2023	186	641	$260,458
2024	202	754	$262,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	29	$1,453
2019	N/R	79	$75,997
2020	N/R	84	$78,300
2021	N/R	24	$40,549
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	117	117	$246,765

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	82	82	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	56	$92
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	35	35	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	97	122	$66
95004	Test for allergy using allergenic extract	76	2,239	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	19	532	$51,911
Breo Ellipta	Fluticasone/Vilanterol	23	1,050	$13,837
Dulera	Mometasone/Formoterol	17	990	$6,444
Advair Hfa	Fluticasone Propion/Salmeterol	15	840	$6,008
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	1,170	$5,392

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	117	117	$246,765

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$1,197	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amee Majmundar, M.D.?

Tedicare shows public-source Medicare data for Amee Majmundar, M.D. (NPI 1093794620), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amee Majmundar, M.D. have ACO affiliation data?

Amee Majmundar, M.D. is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Amee Majmundar, M.D.?

Amee Majmundar, M.D. is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Amee Majmundar, M.D. have Open Payments data?

Amee Majmundar, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.